# Japanese Pharmacokinetic Bridging Study for CC-93538

> **NCT04096105** · PHASE1 · COMPLETED · sponsor: **Celgene** · enrollment: 48 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CC-93538

## Key facts

- **NCT ID:** NCT04096105
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-14
- **Primary completion:** 2020-01-29
- **Final completion:** 2020-01-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096105, "Japanese Pharmacokinetic Bridging Study for CC-93538". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04096105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*